Kane Biotech and ProgenaCare Global Launch Newly Rebranded revyve™ Antimicrobial Wound Gel at Advanced Wound Care Fall Forum
02 nov. 2023 11h48 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech”) in partnership with ProgenaCare Global LLP (“ProgenaCare”) today...
BIOCAPTIVA to conduct ex-vivo study to evaluate the potential of the BioCaptis device to capture cell free DNA to improve pleural disease diagnosis
12 oct. 2023 03h00 HE
|
BIOCAPTIVA
Study aims to establish whether BioCaptis technology can be used to isolate cell free DNA (cfDNA) from pleural fluid samples in sufficient quantities for downstream DNA analysisGoal is to identify...
Canon Medical Celebrates 30th Anniversary of Hybrid Angio-CT Technology with World’s First Deep Learning Spectral CT Reconstruction and HD 76 Technology Integration into Alphenix 4D CT System
28 nov. 2022 09h00 HE
|
Canon Medical Systems USA
Tustin, California, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Canon Medical Systems USA, Inc., a global leader in innovative diagnostic imaging technology, is proud to celebrate the 30th anniversary of...
Happy Bob Integrates With Dexcom CGM to Provide a Playful Way to Engage With Real-Time Glucose Values and Improve Overall Self-Care
08 mars 2022 07h00 HE
|
Harald AI
HELSINKI, March 08, 2022 (GLOBE NEWSWIRE) -- Diabetes tech startup Harald AI today introduced a more expansive way for Dexcom Continuous Glucose Monitoring (CGM) System users to engage with their...
PathMaker Neurosystems Awarded CERF Medical Electronics Prize for Amyotrophic Lateral Sclerosis
07 févr. 2022 06h00 HE
|
PathMaker Neurosystems Inc.
BOSTON, Feb. 07, 2022 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the treatment of...
Diazyme Laboratories, Inc. Announces CE-IVD for its Semi-Quantitative SARS-CoV-2 Neutralizing Antibody Test
01 avr. 2021 17h32 HE
|
General Atomics
SAN DIEGO, April 01, 2021 (GLOBE NEWSWIRE) -- Diazyme Laboratories, Inc. announced March 30th that it has obtained CE-IVD marking for its SARS-CoV-2 neutralizing antibody test. The Diazyme test is a...
Diazyme Laboratories, Inc. Receives Reissued EUA for Semi-Quantitative SARS-CoV-2 IgG Test
23 mars 2021 20h49 HE
|
General Atomics
SAN DIEGO, March 23, 2021 (GLOBE NEWSWIRE) -- Diazyme announces that it has received a reissued Emergency Use Authorization (EUA) for its Semi-Quantitative DZ-Lite SARS-CoV-2 IgG CLIA test which is...